SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Joy Varghese, Mettu Srinivas Reddy, Thomas Cherian, Srinivasan Vijaya, Venkataraman Jayanthi, Mohamed Rela, Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients, Indian Journal of Gastroenterology, 2014, 33, 3, 226

    CrossRef

  2. 2
    Tsung-Hui Hu, Chao-Long Chen, Chih-Che Lin, Chih-Chi Wang, King-Wah Chiu, Chee-Chien Yong, Yueh-Wei Liu, Hock-Liew Eng, Section 14. Combination of Entecavir Plus Low-Dose On-Demand Hepatitis B Immunoglobulin is Effective With Very Low Hepatitis B Recurrence After Liver Transplantation, Transplantation, 2014, 97, S53

    CrossRef

  3. 3
    Edward J. Gane, Scott Patterson, Simone I. Strasser, Geoffrey W. McCaughan, Peter W. Angus, Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen–positive liver transplant candidates, Liver Transplantation, 2013, 19, 3
  4. 4
    Georgios Tsoulfas, Polyxeni Agorastou, Commentary on “Prophylaxis against HBV recurrence after liver transplantation for HBV-related endstage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy”, Journal of Surgical Research, 2013, 183, 2, 548

    CrossRef

  5. 5
    Li Jiang, Lu-Nan Yan, Tian-Fu Wen, Bo Li, Jia-Yin Yang, Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria, Hepatobiliary & Pancreatic Diseases International, 2013, 12, 5, 494

    CrossRef

  6. 6
    L. Jiang, L. Yan, T. Wen, B. Li, J. Zhao, J. Yang, M. Xu, W. Wang, Hepatitis B Prophylaxis Using Lamivudine and Individualized Low-dose Hepatitis B Immunoglobulin in Living Donor Liver Transplantation, Transplantation Proceedings, 2013, 45, 6, 2326

    CrossRef

  7. 7
    Lijuan Feng, Yujian Niu, Hong Chen, Hong You, Yunjin Zang, Li Li, Shan Shan, Yule Tan, Jidong Jia, Zhongyang Shen, Immunogenicity of different hepatitis B virus vaccination schedules in liver transplant recipients, Hepatology Research, 2013, 43, 5
  8. You have free access to this content8
    Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman, Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 1
  9. 9
    Lewis W. Teperman, Fred Poordad, Natalie Bzowej, Paul Martin, Surakit Pungpapong, Thomas Schiano, John Flaherty, Phillip Dinh, Stephen Rossi, G. Mani Subramanian, James Spivey, Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation, Liver Transplantation, 2013, 19, 6
  10. 10
    Kai Wang, Zhi-Jun Zhu, Hong Zheng, Yong-Lin Deng, Cheng Pan, Li-Ying Sun, Zhong-Yang Shen, Protective hepatitis B surface antibodies in blood and ascites fluid in the early stage after liver transplantation for hepatitis B diseases, Hepatology Research, 2012, 42, 3
  11. 11
    Tomohiro Tanaka, Ali Benmousa, Max Marquez, George Therapondos, Eberhard L. Renner, Leslie B. Lilly, The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation, Clinical Transplantation, 2012, 26, 5
  12. 12
    Arianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, Mohammadreza Hafezi, Nuh N. Rahbari, Mohammad Golriz, Ali Majlesara, Morva Tahmasbi Rad, Mahmoud Sadeghi, Jan Schmidt, Tom M. Ganten, The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation, Langenbeck's Archives of Surgery, 2012, 397, 5, 697

    CrossRef

  13. 13
    Corinne Buchanan, Tram T. Tran, Current Status of Liver Transplantation for Hepatitis B Virus, Clinics in Liver Disease, 2011, 15, 4, 753

    CrossRef

  14. 14
    Paolo De Simone, Optimization of hepatitis B virus prophylaxis after liver transplantation, Digestive and Liver Disease Supplements, 2011, 5, 1, 15

    CrossRef

  15. 15
    Jamie L. Berkes, Post-transplant Management of Hepatitis B: Can We Dispense with Hepatitis B Immunoglobulin?, Current Hepatitis Reports, 2011, 10, 2, 142

    CrossRef

  16. 16
    S. Saab, S. Desai, D. Tsaoi, F. Durazo, S. Han, A. McClune, C. Holt, D. Farmer, L. Goldstein, R. W. Busuttil, Posttransplantation Hepatitis B Prophylaxis with Combination Oral Nucleoside and Nucleotide Analog Therapy, American Journal of Transplantation, 2011, 11, 3
  17. 17
    Shin Hwang, Chul-Soo Ahn, Gi-Won Song, Ki-Hun Kim, Deok-Bog Moon, Heung-Bum Oh, Young-Suk Lim, Han Chu Lee, Tae-Yong Ha, Dong-Hwan Jung, Young-Hwa Chung, Sung-Gyu Lee, Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on, Liver Transplantation, 2011, 17, 4
  18. 18
    Ed Gane, Hepatitis B immunoglobulin immunoprophylaxis for hepatitis B: High, low, or no dose?, Liver Transplantation, 2010, 16, S2
  19. 19
    B. Degertekin, Steven-Huy B. Han, E. B. Keeffe, E. R. Schiff, V. A. Luketic, R. S. Brown, Jr., S. Emre, C. Soldevila-Pico, K. R. Reddy, M. B. Ishitani, T. T. Tran, T. L. Pruett, A. S. F. Lok, Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation, American Journal of Transplantation, 2010, 10, 8
  20. 20
    L. Jiang, L. Yan, B. Li, T. Wen, J. Zhao, L. Jiang, N. Cheng, Y. Wei, J. Yang, M. Xu, W. Wang, Prophylaxis Against Hepatitis B Recurrence Posttransplantation Using Lamivudine and Individualized Low-Dose Hepatitis B Immunoglobulin, American Journal of Transplantation, 2010, 10, 8
  21. 21
    Sammy Saab, Maggie Y. Ham, Michael A. Stone, Curtis Holt, Myron Tong, Decision analysis model for hepatitis B prophylaxis one year after liver transplantation, Liver Transplantation, 2009, 15, 4
  22. 22
    Maki Yamamoto, Gregg Little, David K Imagawa, Hepatitis B immunoglobulin in preventing reinfection following liver transplantation, Expert Review of Anti-infective Therapy, 2009, 7, 3, 321

    CrossRef

  23. 23
    Scott J Patterson, Peter W Angus, Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues, Current Opinion in Organ Transplantation, 2009, 14, 3, 225

    CrossRef

  24. 24
    Sammy Saab, Melina Yeganeh, Kelvin Nguyen, Francisco Durazo, Steven Han, Hasan Yersiz, Douglas G. Farmer, Leonard I. Goldstein, Myron J. Tong, Ronald W. Busuttil, Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen–positive patients after liver transplantation, Liver Transplantation, 2009, 15, 11
  25. 25
    Peter W. Angus, Scott J. Patterson, Simone I. Strasser, Geoffrey W. McCaughan, Edward Gane, A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post–liver transplantation hepatitis B prophylaxis, Hepatology, 2008, 48, 5
  26. 26
    Stephen Barclay, Stanislas Pol, David Mutimer, Yves Benhamou, Peter R. Mills, Peter C. Hayes, Sheila Cameron, William Carman, Erratum to ‘The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting’ [J. Clin. Virol. 41 (4) 2008 243–254], Journal of Clinical Virology, 2008, 42, 1, 104

    CrossRef

  27. 27
    A.W. Avolio, E. Nure, M. Pompili, R. Barbarino, M. Basso, L. Caccamo, S. Magalini, S. Agnes, M. Castagneto, Liver Transplantation for Hepatitis B Virus Patients: Long-Term Results of Three Therapeutic Approaches, Transplantation Proceedings, 2008, 40, 6, 1961

    CrossRef

  28. 28
    Peter W. Angus, Scott J. Patterson, Liver transplantation for hepatitis B: What is the best hepatitis B immune globulin/antiviral regimen?, Liver Transplantation, 2008, 14, S2
  29. 29
    Stephen Barclay, Stanislas Pol, David Mutimer, Yves Benhamou, Peter R. Mills, Peter C. Hayes, Sheila Cameron, William Cameron, The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting, Journal of Clinical Virology, 2008, 41, 4, 243

    CrossRef

  30. 30
    Holbrook E. Kohrt, Daniel L. Ouyang, Emmet B. Keeffe, Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection, Clinics in Liver Disease, 2007, 11, 4, 965

    CrossRef

  31. 31
    Mark W Russo, Current concepts in the evaluation of patients for liver transplantation, Expert Review of Gastroenterology & Hepatology, 2007, 1, 2, 307

    CrossRef

  32. 32
    C.-M. Lo, G. K. Lau, S.-C. Chan, S.-T. Fan, J. Wong, Efficacy of a Pre-S Containing Vaccine in Patients Receiving Lamivudine Prophylaxis after Liver Transplantation for Chronic Hepatitis B, American Journal of Transplantation, 2007, 7, 2
  33. 33
    Stephen N. Wong, Chi-Jen Chu, Chun-Tao Wai, Terese Howell, Charles Moore, Robert J. Fontana, Anna S.F. Lok, Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy, Liver Transplantation, 2007, 13, 3
  34. 34
    Lucio Caccamo, Francesca Agnelli, Paolo Reggiani, Umberto Maggi, M Francesca Donato, Stefano Gatti, Giovanni Paone, Ernesto Melada, Giorgio Rossi, Role of Lamivudine in the Posttransplant Prophylaxis of Chronic Hepatitis B Virus and Hepatitis Delta Virus Coinfection, Transplantation, 2007, 83, 10, 1341

    CrossRef

  35. 35
    Medical Complications of Kidney Transplantation, 2007,

    CrossRef

  36. 36
    Robert G. Gish, Timothy McCashland, Hepatitis B in liver transplant recipients, Liver Transplantation, 2006, 12, S2
  37. 37
    Ed Gane, Prevention and Treatment of Recurrent HBV and HCV Infection,